UnitedHealth Group Inc (NYSE:UNH) Shares Acquired by Strategic Advisors LLC

Strategic Advisors LLC lifted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.4% during the 2nd quarter, HoldingsChannel reports. The firm owned 4,851 shares of the healthcare conglomerate’s stock after purchasing an additional 65 shares during the quarter. Strategic Advisors LLC’s holdings in UnitedHealth Group were worth $1,183,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Canton Hathaway LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $36,000. Truvestments Capital LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $42,000. Creative Financial Designs Inc. ADV boosted its holdings in shares of UnitedHealth Group by 89.6% during the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock worth $50,000 after purchasing an additional 95 shares during the last quarter. Financial Gravity Wealth Inc. acquired a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $58,000. Finally, Horan Capital Advisors LLC. acquired a new position in UnitedHealth Group in the first quarter valued at approximately $68,000. Institutional investors and hedge funds own 85.87% of the company’s stock.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $239.02, for a total value of $1,195,100.00. Following the sale, the director now owns 77,993 shares of the company’s stock, valued at $18,641,886.86. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the company’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total value of $3,063,720.00. Following the sale, the director now directly owns 61,309 shares in the company, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. In the last three months, insiders sold 37,000 shares of company stock worth $9,158,720. 0.87% of the stock is owned by corporate insiders.

NYSE UNH traded down $2.07 on Friday, reaching $247.18. The stock had a trading volume of 964,059 shares, compared to its average volume of 3,551,316. The company has a market capitalization of $242.27 billion, a price-to-earnings ratio of 19.19, a price-to-earnings-growth ratio of 1.36 and a beta of 0.61. The company has a quick ratio of 0.73, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94. The company’s fifty day moving average price is $251.46.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.46 by $0.14. The company had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.14 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Inc will post 14.82 earnings per share for the current year.

UNH has been the topic of a number of recent analyst reports. UBS Group initiated coverage on UnitedHealth Group in a report on Tuesday, April 23rd. They issued a “neutral” rating and a $238.00 price objective on the stock. ValuEngine cut UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday, April 18th. Cantor Fitzgerald set a $310.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Barclays decreased their price objective on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating on the stock in a report on Wednesday, April 17th. Finally, Cleveland Research reiterated a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 15th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $295.06.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: Analyst Ratings Trading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.